Effects of propofol on sleep architecture and sleep–wake systems in rats

• Published in: Behavioural brain research 2021-08, Vol.411, p.113380-113380, Article 113380
• Main Authors: Yue, Xiao-Fang, Wang, Ai-Zhong, Hou, Yi-Ping, Fan, Kun
• Format: Article
• Language: English
• Subjects: Anaesthetic; Animals; Circadian Rhythm - drug effects; Circadian Rhythm - physiology; Electroencephalogram; Electroencephalography - methods; Injections, Intraperitoneal; Male; Propofol; Propofol - administration & dosage; Propofol - metabolism; Propofol - pharmacology; Rats; Rats, Sprague-Dawley; Sleep; Sleep - drug effects; Sleep - physiology; Sleep Latency - drug effects; Sleep Latency - physiology; Sleep Stages - drug effects; Sleep, Slow-Wave - drug effects; Sleep, Slow-Wave - physiology; Wake; Wakefulness - drug effects; Wakefulness - physiology
• ISSN: 0166-4328; 1872-7549
• DOI: 10.1016/j.bbr.2021.113380

[Display omitted] •A high dose of propofol produced high-quality sleep by increasing slow-wave sleep.•A medium dose of propofol produced fragmented and low-quality sleep by disrupting the continuity of wakefulness.•Propofol significantly shortened sleep latency and did not affect the sleep rhythm.•Sleep induced by propofol is related to modulation of sleep and wake-specific systems. Previous studies have shown that the synchronization of electroencephalogram (EEG) signals is found during propofol-induced general anesthesia, which is similar to that of slow-wave sleep (SWS). However, a complete understanding is lacking in terms of the characteristics of EEG changes in rats after propofol administration and whether propofol acts through natural sleep circuits. Here, we examined the characteristics of EEG patterns induced by intraperitoneal injection of propofol in rats. We found that high (10 mg/kg) and medium (5 mg/kg) doses of propofol induced a cortical EEG of low-frequency, high-amplitude activity with rare electromyographic activity and markedly shortened sleep latency. The high dose of propofol increased deep slow-wave sleep (SWS2) to 4 h, as well as the number of large SWS2 bouts (>480 s), their mean duration and the peak of the power density curve in the delta range of 0.75–3.25 Hz. After the medium dose of propofol, the total number of wakefulness, light slow-wave sleep (SWS1) and SWS2 episodes increased, whereas the mean duration of wakefulness decreased. The high dose of propofol significantly increased c-fos expression in the ventrolateral preoptic nucleus (VLPO) sleep center and decreased the number of c-fos-immunoreactive neurons in wake-related systems including the tuberomammillary nucleus (TMN), perifornical nucleus (PeF), lateral hypothalamic nucleus (LH), ventrolateral periaqueductal gray (vPAG) and supramammillary region (SuM). These results indicated that the high dose of propofol produced high-quality sleep by increasing SWS2, whereas the medium dose produced fragmented and low-quality sleep by disrupting the continuity of wakefulness. Furthermore, sleep-promoting effects of propofol are correlated with activation of the VLPO cluster and inhibition of the TMN, PeF, LH, vPAG and SuM.